Search Results - "Santoni-Rugiu, E."

Targeting MET amplification in non-small cell lung cancer: encouraging results with vebreltinib from the phase II KUNPENG study.

Authors: Urbanska EM Grauslund M Sørensen JB et al.

Source: Translational lung cancer research [Transl Lung Cancer Res] 2026 Jun 30; Vol. 15 (6), pp. 160. Date of Electronic Publication: 2026 Jun 16.

Publication Type: Editorial; Comment

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE

Are lazertinib and osimertinib comparable for treating advanced EGFR-mutant non-small cell lung cancer?-insights and limitations from the MARIPOSA study.

Authors: Urbanska EM Santoni-Rugiu E Grauslund M et al.

Source: Journal of thoracic disease [J Thorac Dis] 2026 May 31; Vol. 18 (5), pp. 559. Date of Electronic Publication: 2026 May 27.

Publication Type: Editorial; Comment

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101533916 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2072-1439 (Print) Linking ISSN: 20721439 NLM ISO Abbreviation: J Thorac Dis Subsets: PubMed not MEDLINE

Multilocus Inherited Neoplasia Alleles Syndrome in a Patient With BRCA2‐Associated Breast Cancer and MLH1‐Related Lynch Syndrome.

Authors: Avila-Rodriguez, Vaneza Ruiz-Patiño, Alejandro Bonilla-Gonzalez, Carlos et al.

Source: Case Reports in Oncological Medicine. 4/19/2026, Vol. 2026, p1-6. 6p.

Precision at the Margin: Innovations and Challenges in Intraoperative Molecular Imaging for Thoracic Surgery.

Authors: Rabinovich, Emily P. Martin, Linda W.

Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 12, p4493. 12p.

Advances in diagnosis and management of pleural mesothelioma: the Danish clinical guidelines.

Authors: Panou V Sørensen JB Ravn J et al.

Source: European clinical respiratory journal [Eur Clin Respir J] 2025 Oct 29; Vol. 12 (1), pp. 2580795. Date of Electronic Publication: 2025 Oct 29 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101662134 Publication Model: eCollection Cited Medium: Print ISSN: 2001-8525 (Print) Linking ISSN: 20018525 NLM ISO Abbreviation: Eur Clin Respir J Subsets: PubMed not MEDLINE

Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors.

Authors: Egebjerg K Spanggaard I Ahlborn LB et al.

Source: BMC cancer [BMC Cancer] 2025 Aug 06; Vol. 25 (1), pp. 1272. Date of Electronic Publication: 2025 Aug 06.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Clonal divergence with acquired BRAF V600E in NSCLC with compound EGFR G719X/S768I after prolonged EGFR-TKI therapy.

Authors: Hviid C Melchior LC Berger SMS et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Aug; Vol. 218, pp. 109517. Date of Electronic Publication: 2026 Jul 01.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Histological fidelity and microenvironmental kinome signatures of metastatic patient-derived organoids.

Authors: Leitão-Castro J Lopresti AM Zornhagen KW et al.

Source: Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2026 Apr 02; Vol. 14, pp. 1735980. Date of Electronic Publication: 2026 Apr 02 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101632513 Publication Model: eCollection Cited Medium: Print ISSN: 2296-4185 (Print) Linking ISSN: 22964185 NLM ISO Abbreviation: Front Bioeng Biotechnol Subsets: PubMed not MEDLINE

Author Index.

Source: APMIS. Mar2012, Vol. 120, p40-41. 24p.

The Accuracy of Video-Assisted Thoracic Surgery Pleural Biopsy in Patients with Suspected Diffuse Pleural Mesothelioma: A Real-Life Study.

Authors: Balsamo, Ludovica Migliore, Enrica Della Beffa, Eleonora et al.

Source: Journal of Clinical Medicine. Jan2026, Vol. 15 Issue 1, p42. 15p.

Combinational BET and mTOR inhibition unveils EGR1 as acute myeloid leukemia prognostic biomarker.

Authors: Latancia, Marcela Teatin Silva, Wellington Fernandes da Bragança-Jardim, Elayne et al.

Source: Scientific Reports. 11/18/2025, Vol. 15 Issue 1, p1-16. 16p.

Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine Platform.

Authors: Kjølle, Silje Presti, Mario Roque, Jéssica de Pina et al.

Source: Cells (2073-4409). Feb2026, Vol. 15 Issue 3, p259. 22p.

Author Index – Volume 18.

Source: Oncogene. 12/23/99, Vol. 18 Issue 56, p8048. 19p.

The Expression and Regulation of the Nuclear Receptor-Binding SET Domain Protein 2 in Parotid Carcinoma.

Authors: Gu, Min Ge, Junyi Pan, Qianjia et al.

Source: Indian Journal of Otolaryngology & Head & Neck Surgery (Springer Nature). Oct2025, Vol. 77 Issue 10, p4122-4128. 7p.

Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer.

Authors: Sakamoto, Yasunari Morizane, Chigusa Okusaka, Takuji et al.

Source: Scientific Reports. 9/30/2025, Vol. 15 Issue 1, p1-11. 11p.

Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 ⁺ or ALK ⁺ non-small cell lung cancer to crizotinib therapy.

Authors: Jie H Lai H Wang Z et al.

Source: Translational lung cancer research [Transl Lung Cancer Res] 2025 Mar 31; Vol. 14 (3), pp. 878-896. Date of Electronic Publication: 2025 Mar 27.

Publication Type: Journal Article

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE

Alectinib impressively enters the adjuvant setting for early-stage ALK-rearranged non-small cell lung cancer and outperforms chemotherapy-let's define who benefits the most.

Authors: Santoni-Rugiu E Sørensen JB Urbanska EM

Source: Translational lung cancer research [Transl Lung Cancer Res] 2025 Feb 28; Vol. 14 (2), pp. 310-313. Date of Electronic Publication: 2025 Feb 21.

Publication Type: Editorial; Comment

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE

Placenta-Derived Secretions Promote Liver Dysfunction, and Hepatic Serum Amyloid A Mediates Kidney Inflammatory Response in a Preeclampsia-like Mouse Model.

Authors: Ozawa, Ren Suzuki, Sae Shirota, Ayaka et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10737. 15p.

Prevalence of Histological Transformation in First-Line Osimertinib Non-Small Cell Lung Cancers: Case Series and Literature Review.

Authors: Sparavelli, Rebecca Bruno, Rossella Celi, Alessandra et al.

Source: International Journal of Molecular Sciences. Nov2025, Vol. 26 Issue 21, p10462. 16p.

ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.

Authors: Urbanska EM Grauslund M Berger SMS et al.

Source: Translational lung cancer research [Transl Lung Cancer Res] 2024 Sep 30; Vol. 13 (9), pp. 2453-2462. Date of Electronic Publication: 2024 Sep 26.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE